bluebird bio, Inc. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 8 rows, 8 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-03-09: Reporting owner Jones-Burton Charlotte; Form 3; Security No Securities are beneficially owned; Transaction Holding.
- 2021-11-11: Reporting owner Leschly Nick; Form 4; Security Common Stock; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2015-06-10: Reporting owner Walsh Jeffrey T.; Form 4; Security Stock Otpion (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-05-11: Reporting owner Walsh Jeffrey T.; Form 4; Security Stock Otpion (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-03-09 holding as of filing | Jones-Burton Charlotte Director | 3 | No Securities are beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2022-03-09 | |
| 2021-11-11 | Leschly Nick Director | 4 | Common Stock Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −100,000 98,454 owned after | $67.06 exercise price | 2021-11-17 | |
| 2015-06-10 | Walsh Jeffrey T. Officer (Chief Operating Officer) | 4 | Stock Otpion (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −545 12,235 owned after | $2.09 exercise price | 2015-06-11 | |
| 2015-05-11 | Walsh Jeffrey T. Officer (Chief Operating Officer) | 4 | Stock Otpion (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −545 12,780 owned after | $2.09 exercise price | 2015-05-13 | |
| 2014-12-08 | Davidson David Officer (Chief Medical Officer) | 4 | Stock Otpion (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,788 67,239 owned after | $2.09 exercise price | 2014-12-09 | |
| 2014-07-18 holding as of filing | Vachon Mark Director | 3 | No securities are beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2014-07-18 | |
| 2014-03-12 holding as of filing | Cole Jason Officer (SVP, Secy. & General Counsel) | 3 | No securities are beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2014-03-12 | |
| 2014-01-10 holding as of filing | Mandell James Director | 3 | No securities are beneficially owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2014-01-10 |